当前位置:首页 - 行情中心 - 信隆健康(002105) - 财务分析 - 利润表

信隆健康

(002105)

  

流通市值:17.57亿  总市值:17.75亿
流通股本:3.64亿   总股本:3.68亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入739,166,037.27523,575,071.38271,574,492.331,824,864,770.48
营业收入739,166,037.27523,575,071.38271,574,492.331,824,864,770.48
二、营业总成本731,155,214.55497,518,228.94262,461,202.421,598,361,551.03
营业成本604,693,798.29417,417,691.41216,151,006.191,396,124,231.44
税金及附加7,400,852.276,119,499.182,618,369.5717,818,190.94
销售费用22,205,040.1515,189,891.676,504,342.5835,531,750.25
管理费用62,979,912.8141,965,036.8418,999,780.03108,474,600.89
研发费用34,001,446.8720,878,806.689,657,865.3956,584,713.15
财务费用-125,835.84-4,052,696.848,529,838.66-16,171,935.64
其中:利息费用12,898,819.068,460,895.044,482,285.9725,637,955.54
其中:利息收入5,670,808.483,392,965.41,820,544.363,786,090.25
加:公允价值变动收益--13,580238,609.05-
加:投资收益674,752.93-1,378,790.21-434,770.44-8,069,370.67
资产处置收益42,485.2939,816.05-40,952.24582,913.9
资产减值损失(新)-231,184.41-1,873,411.92-231,184.41-10,954,352.74
信用减值损失(新)1,247,379.653,203,904.552,910,724.816,737,997.23
其他收益3,460,749.022,753,580.68326,633.3410,703,328.22
营业利润平衡项目0000
四、营业利润13,205,005.228,788,361.5911,882,350.02225,503,735.39
加:营业外收入13,580,782.938,961,067.014,445,836.2718,192,926.93
减:营业外支出2,574,601.881,366,504.496,918.554,457,156.45
利润总额平衡项目0000
五、利润总额24,211,186.2536,382,924.216,231,267.74239,239,505.87
减:所得税费用5,553,039.166,441,433.853,450,050.6331,759,351.77
六、净利润18,658,147.0929,941,490.3512,781,217.11207,480,154.1
持续经营净利润18,658,147.0929,941,490.3512,781,217.11207,480,154.1
归属于母公司股东的净利润22,132,285.2331,177,055.2812,528,280.11189,175,677.04
少数股东损益-3,474,138.14-1,235,564.93252,93718,304,477.06
(一)基本每股收益0.060.090.030.52
(二)稀释每股收益0.060.090.030.52
八、其他综合收益-7,217,230.074,211,121.08-2,264,297.058,114,452.82
归属于母公司股东的其他综合收益-4,878,397.091,662,001.5-2,010,689.293,849,715.66
九、综合收益总额11,440,917.0234,152,611.4310,516,920.06215,594,606.92
归属于母公司股东的综合收益总额17,253,888.1432,839,056.7810,517,590.82193,025,392.7
归属于少数股东的综合收益总额-5,812,971.121,313,554.65-670.7622,569,214.22
公告日期2023-10-282023-08-262023-04-262023-03-17
审计意见(境内)标准无保留意见
TOP↑